TR200000958T2 - The use of thiazolidinedione in the treatment of hyperglycemia. - Google Patents

The use of thiazolidinedione in the treatment of hyperglycemia.

Info

Publication number
TR200000958T2
TR200000958T2 TR2000/00958T TR200000958T TR200000958T2 TR 200000958 T2 TR200000958 T2 TR 200000958T2 TR 2000/00958 T TR2000/00958 T TR 2000/00958T TR 200000958 T TR200000958 T TR 200000958T TR 200000958 T2 TR200000958 T2 TR 200000958T2
Authority
TR
Turkey
Prior art keywords
hyperglycemia
thiazolidinedione
treatment
mammal
toxic
Prior art date
Application number
TR2000/00958T
Other languages
Turkish (tr)
Inventor
Edwin Buckingham Robin
Alistair Smith Stephan
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200000958T2 publication Critical patent/TR200000958T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

Plazma glükoz seviyelerinin yüksek normal <=126mg/dl, arasinda oldugu hiperglisemi tedavisi için, ihtiyaci olan memeliye etkili toksik olmayan ve farmasötik olarak kabul edilebilir miktarda bir ensülin sensitizörü uygulanmasini içeren bir yöntem.A method of treating hyperglycemia in which plasma glucose levels are between high normal <= 126mg / dl, and applying a non-toxic and pharmaceutically acceptable amount of insulin sensitizer to the mammal in need.

TR2000/00958T 1997-10-13 1998-10-12 The use of thiazolidinedione in the treatment of hyperglycemia. TR200000958T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment

Publications (1)

Publication Number Publication Date
TR200000958T2 true TR200000958T2 (en) 2000-08-21

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00958T TR200000958T2 (en) 1997-10-13 1998-10-12 The use of thiazolidinedione in the treatment of hyperglycemia.

Country Status (24)

Country Link
EP (1) EP1023056A1 (en)
JP (1) JP2001519382A (en)
KR (1) KR20010024481A (en)
CN (1) CN1281359A (en)
AP (1) AP2000001787A0 (en)
AU (1) AU9547098A (en)
BG (1) BG104404A (en)
BR (1) BR9815219A (en)
CA (1) CA2306086A1 (en)
CZ (1) CZ20001297A3 (en)
EA (1) EA002659B1 (en)
GB (1) GB9721693D0 (en)
HR (1) HRP20000255A2 (en)
HU (1) HUP0003922A3 (en)
ID (1) ID24521A (en)
IL (1) IL135513A0 (en)
NO (1) NO20001898L (en)
NZ (1) NZ503862A (en)
OA (1) OA11683A (en)
PL (1) PL339813A1 (en)
SK (1) SK5312000A3 (en)
TR (1) TR200000958T2 (en)
WO (1) WO1999018943A1 (en)
YU (1) YU28800A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (en) * 1987-09-04 2000-05-11 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
IL135513A0 (en) 2001-05-20
NO20001898L (en) 2000-06-09
SK5312000A3 (en) 2000-09-12
EA200000419A1 (en) 2000-10-30
HUP0003922A2 (en) 2001-10-28
BG104404A (en) 2000-12-29
NZ503862A (en) 2003-01-31
OA11683A (en) 2005-01-12
CA2306086A1 (en) 1999-04-22
CN1281359A (en) 2001-01-24
WO1999018943A1 (en) 1999-04-22
EA002659B1 (en) 2002-08-29
AP2000001787A0 (en) 2000-06-30
GB9721693D0 (en) 1997-12-10
PL339813A1 (en) 2001-01-02
EP1023056A1 (en) 2000-08-02
BR9815219A (en) 2001-01-02
NO20001898D0 (en) 2000-04-12
JP2001519382A (en) 2001-10-23
AU9547098A (en) 1999-05-03
YU28800A (en) 2003-02-28
HUP0003922A3 (en) 2001-12-28
CZ20001297A3 (en) 2001-08-15
KR20010024481A (en) 2001-03-26
ID24521A (en) 2000-07-20
HRP20000255A2 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
TR200100079T2 (en) Glucagon-like peptide-1, which increases the ß-cell response to glucose
SG127714A1 (en) Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes
EA200101089A1 (en) NEW METHOD OF TREATMENT
DK1373215T3 (en) Gelanamycin derivatives suitable for the treatment of cancer
MXPA03003870A (en) Combination therapy comprising anti-diabetic and anticonvulsant agents.
TR199902033T2 (en) Sulfonylura-glitazone synergistic combinations for diabetes.
DK1083899T3 (en) Derivatives of 1-dexoy-galactonojirimycin and its use in the treatment of lysosomal storage disorders by increasing lysosomal alpha-galactosidase A
TR199903057T2 (en) Treatment of diabetes with thiazolidinedione and metformin.
TR200101174T2 (en) 5HT1, receptor agonists and metoclopramide for migraine treatment.
IL143569A0 (en) A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes
BR0311161A (en) Diabetes Treatment Method
NO20083276L (en) Treatment of diabetes with thiazolidinedione and sulfonylurea
MY155219A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide
TR199901003T2 (en) Composition containing loratadine and a decongestant for the treatment of asthma.
CY1107745T1 (en) TREATMENT OF DIABETES WITH THIAZOLIDINODION AND SULFONYLURIA
TR199903095T2 (en) Treatment of diabetes with rosiglitazone and insulin.
TR200000958T2 (en) The use of thiazolidinedione in the treatment of hyperglycemia.
TR200101336T2 (en) Combinations with a beta-agonist and another antidiabetic agent
NO996270L (en) Treatment of diabetes with thiazolidinedione and &lt;alfa&gt; glucosidase inhibitor
AR019724A2 (en) PHARMACEUTICAL COMPOSITION USEFUL FOR THE TREATMENT OF MELLITUS DIABETES AND ASSOCIATED CONDITIONS
TR200000957T2 (en) The use of thiazolidinedione in the treatment of hyperglycemia
NO20003813L (en) Procedures for reducing or preventing pain when using spicamycin or its derivatives
TR200202033T2 (en) Preparations and Methods for Epilepsy Treatment
AU4193800A (en) Use of tagatose to enhance key blood factors
WO2001047509A3 (en) Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions